Investor (INVE) investor relations material

Opening remarks and agenda

• Meeting opened with election of Eva Hägg as chair and Pia Faaredig as secretary; agenda approved and practical matters addressed.

• CEO Christian Cederholm addressed shareholders, emphasizing the company's long-term commitment to value creation since 1916.

• Shareholders could participate in person, by postal vote, or via webcast; voting devices used for resolutions requiring a qualified majority.

Financial performance review

• Adjusted net asset value reached SEK 1,087 billion, with a 14% annual growth rate over five years.

• Total return for shares was 15%, reflecting strong performance compared to benchmarks.

• Listed companies achieved 9% profit growth; SEK 29 billion invested across business areas, including the largest-ever acquisition (Nova Biomedical for $2.2 billion).

• Dividend per share has grown at an average annual rate of 8% over the past decade.

• Portfolio companies have delivered consistent returns over 1, 5, 10, and 20-year periods.

Board and executive committee updates

• Board composition reduced to 11 members; Tom Johnstone and Isabelle Kocher stepped down, with thanks for their contributions.

• Jacob Wallenberg re-elected as chair; board evaluation showed high attendance and effective functioning.

• Board fees increased by 7% to remain competitive; policy for directors to hold shares equivalent to 1.5 years' fees.